Application for approval of Wynzora® Cream (calcipotriol and betamethasone dipropionate) for the treatment of plaque psoriasis submitted to the EU

The application is supported by two Phase III trials, including an EU study in which the proportion of patients experiencing treatment success (achievement of ≥2-point improvement in PGA) was higher than with Dovobet® gel, with improved patient acceptability.


Biospace Inc.